湖南恒光科技股份有限公司 第五届监事会第十次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 湖南恒光科技股份有限公司（以下简称"公司"）第五届监事会第十次会议 于 2025 年 4 月 17 日在衡阳市松木经济开发区上倪路湖南恒光化工有限公司会议 室以现场会议的方式召开。会议通知于 2025 年 4 月 7 日以电子邮件等方式送达 各位监事。本次会议应出席监事 3 人，实际出席监事 3 人。会议由公司监事会主 席胡建新先生主持。本次监事会会议的召集、召开和表决程序符合《中华人民共 和国公司法》（以下简称"《公司法》"）和《公司章程》等相关规定。 二、监事会会议审议情况 证券代码：301118 证券简称：恒光股份 公告编号：2025-018 经与会监事认真审议，形成如下决议： 1、会议以 3 票同意、0 票反对、0 票弃权的表决情况审议通过了《关于<2024 年年度报告>及其摘要的议案》 经审议，监事会认为：董事会编制和审核公司《2024 年年度报告》及其摘 要的程序符合相关法律法规和中国证监会的有关规定，报告的内容真实、准 ...

湖南恒光科技股份有限公司 第五届董事会第十三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 证券代码：301118 证券简称：恒光股份 公告编号：2025-017 湖南恒光科技股份有限公司（以下简称"公司"）第五届董事会第十三次会 议于 2025 年 4 月 17 日在衡阳市松木经济开发区上倪路湖南恒光化工有限公司会 议室以现场表决的方式召开。会议通知于 2025 年 4 月 7 日以电子邮件等方式送 达各位董事。本次会议应出席董事 7 人，实际出席董事 7 人。会议由公司董事长 曹立祥先生主持，全体监事及高级管理人员列席会议。本次董事会会议的召集、 召开和表决程序符合《中华人民共和国公司法》（以下简称"《公司法》"）和 《公司章程》等相关规定。 二、董事会会议审议情况 经与会董事认真审议，形成如下决议： 1、会议以 7 票同意、0 票反对、0 票弃权的表决情况审议通过了《关于<2024 年年度报告>及其摘要的议案》 经审议，董事会认为：公司《2024 年年度报告》及其摘要内容真实、准确、 完整地反映了公司 2024 年 ...

证券代码：301118 证券简称：恒光股份 公告编号：2025-021 湖南恒光科技股份有限公司 关于 2024 年度利润分配预案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、审议程序 湖南恒光科技股份有限公司（以下简称"公司"）于 2025 年 4 月 17 日召开 第五届董事会第十三次会议和第五届监事会第十次会议，分别审议通过了《关于 <2024 年度利润分配预案>的议案》，本议案尚需提交公司 2024 年年度股东大会 审议。 二、利润分配预案基本情况 （一）本次利润分配预案的基本内容 1、本次利润分配预案为 2024 年度利润分配预案。 2、经大信会计师事务所（特殊普通合伙）审计，2024 年度合并报表中归属 于上市公司股东的净利润为-60,931,555.82 元，其中 2024 年母公司亏损 36,209,017.81 元。截至 2024 年 12 月 31 日，合并报表中可供分配的利润为 443,442,920.01 元，母公司可供分配利润为 344,726,529.25 元。根据利润分配 应以母公司的可供分配利润及合并报表的可供分配 ...

Financial Performance - The company reported a significant loss due to low product gross margins in the chemical industry, which is currently in a low prosperity cycle [4][5]. - The company's operating revenue for 2024 reached ¥1,234,857,956.20, representing a 31.87% increase compared to ¥936,430,932.93 in 2023 [21]. - The net profit attributable to shareholders was -¥60,931,555.82 in 2024, a decline of 62.26% from -¥37,551,777.73 in 2023 [21]. - The basic earnings per share for 2024 was -¥0.5712, down 62.27% from -¥0.3520 in 2023 [21]. - The total assets at the end of 2024 amounted to ¥2,545,091,018.57, a 6.53% increase from ¥2,389,157,257.17 at the end of 2023 [21]. - The net assets attributable to shareholders decreased by 3.74% to ¥1,335,437,147.73 at the end of 2024 from ¥1,387,366,799.54 at the end of 2023 [21]. - The cash flow from operating activities for 2024 was ¥30,968,784.87, a decrease of 16.20% compared to ¥36,957,404.32 in 2023 [21]. - The company reported a total of ¥18,079,667.49 in non-recurring gains and losses for 2024 [28]. - The company experienced a negative cash flow from operating activities in the first three quarters of 2024, with a net cash flow of ¥105,040,192.02 in Q4 [24]. Industry Challenges - The increase in energy prices following market reforms has contributed to rising production costs, impacting overall profitability [4]. - The chemical industry is cyclical, and the company is currently navigating through a downturn in market conditions [5]. - The chemical industry faced challenges in 2024 due to weak demand and high energy costs, impacting overall profitability [31]. - The chlor-alkali industry in 2024 is expected to be dominated by capacity expansion, with overall performance showing a relatively weak trend [33]. - In the first half of the year, supply-demand imbalance intensified due to increased supply and slowing demand, leading to price pressure; however, a rebound was observed in the second half due to stable demand growth [33]. Production and Capacity - The company is gradually releasing production capacity for products such as chlor-alkali, amino sulfonic acid, and magnesium sulfate, which has led to higher fixed costs [4]. - The production capacity utilization rate for sodium chlorate is at 100.32%, indicating efficient production [36]. - The company plans to complete the expansion of 30,000 tons of amino sulfonic acid by June 2024 [36]. - The company operates in multiple chemical parks, producing a variety of products including sulfuric acid, sodium chlorate, and hydrochloric acid, contributing to diverse revenue streams [36]. - The chlor-alkali product chain produced 71.57 million tons with sales of 59.72 million tons, generating revenue of approximately ¥948.37 million, showing slight price fluctuations [72]. - The sulfur chemical product chain produced 77.47 million tons with sales of 59.55 million tons, generating revenue of approximately ¥283.12 million, also reflecting slight price fluctuations [72]. - In 2024, the company achieved a sales volume of 119.28 million tons, a year-on-year increase of 17.59%, and a production volume of 149.05 million tons, up 20.23% from 2023 [73]. Research and Development - The company has a total of 4 authorized patents for sodium chlorate, with a dedicated R&D team continuously improving technology [36]. - The company holds 51 patents focused on production process innovations, which are crucial for maintaining cost and environmental advantages [52]. - Research and development expenses increased by 15.63% year-on-year, totaling approximately ¥46.39 million [84]. - The company is focusing on enhancing its core competitiveness through the development of advanced production technologies and expanding its market presence [85]. - The company is investing 100 million yuan in research and development for innovative technologies in the next fiscal year [157]. Environmental Compliance - The company has maintained compliance with environmental regulations but faces risks related to potential pollution incidents and increasing environmental protection costs [129]. - The company holds a valid pollution discharge permit obtained on June 23, 2024, effective until June 22, 2029 [191]. - The company adheres to multiple environmental protection laws and standards during its production activities [190]. - The total wastewater discharge from Hunan Hengguang Technology Co., Ltd. is reported at 1.7 tons, with a chemical oxygen demand of 18.9 mg/L [194]. - The company achieved a particulate matter emission of 1 g/m³ from its industrial wastewater treatment, adhering to the GB26132-2010 standard [195]. - The company has achieved compliance with various environmental discharge standards across multiple pollutants [196][197]. Corporate Governance - The company held several board meetings during the reporting period, ensuring compliance with legal and regulatory requirements [134]. - The board of directors consists of 7 members, including 3 independent directors, meeting the regulatory standards [135]. - The company maintains independence from its controlling shareholder, with no interference in decision-making or operations [137]. - The company emphasizes transparency in information disclosure, adhering to relevant laws and regulations [138]. - The company has established a fair and effective performance evaluation and incentive mechanism for its senior management [139]. Employee and Shareholder Relations - The company implemented a cash dividend policy, distributing 1.25 RMB per 10 shares, totaling 13,800,000 RMB, which represents 100% of the profit distribution amount [176][177]. - The employee composition includes 557 production personnel, 20 sales personnel, 19 technical personnel, 18 financial personnel, and 309 administrative personnel [170]. - The company has established a comprehensive talent development plan and training system to enhance business support and management capabilities [173]. - The company has zero retired employees requiring financial support, indicating a focus on retaining talent [170]. - The company has a structured approach to employee compensation, focusing on internal fairness and external competitiveness [171]. Future Outlook - The company anticipates a positive outlook for the next fiscal year, projecting growth in revenue and market share based on current performance metrics [151]. - The company plans to continue expanding its market presence and enhancing product development strategies [1]. - Future guidance indicates a focus on technological advancements and potential mergers and acquisitions [1].

证券代码：301118 证券简称：恒光股份 公告编号：2025-016 湖南恒光科技股份有限公司 关于持股 5%以上股东减持股份的预披露公告 持股 5%以上的股东湘江产业投资有限责任公司保证向本公司提供的信息内 容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 湖南恒光科技股份有限公司（以下简称"公司"或"恒光股份"）股东湘江 产业投资有限责任公司（以下简称"湘江投资"）现持有公司股份11,560,000 股，占公司总股本的10.47%，拟自本公告披露之日起15个交易日后的3个月内 （2025年5月14日至2025年8月13日）以集中竞价或大宗交易方式减持公司股份不 超过330万股，即不超过公司当前总股本的2.99%。如遇公司股票在减持期间发生 除权、除息事项的，减持股份数量作相应调整。 近日，公司收到持股5%以上股份的股东湘江投资出具的《减持股份告知函》， 现将相关情况公告如下： 一、股东的基本情况 （一）股东名称：湘江产业投资有限责任公司 （二）股东持有股份的总数量：11,560,000股 湘江投资系在中国证券投资基金 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、募集资金的情况概述 经中国证券监督管理委员会（以下简称"中国证监会"）《关于同意湖南恒 光科技股份有限公司首次公开发行股票注册的批复》（证监许可[2021]3257 号） 同意注册，湖南恒光科技股份有限公司（以下简称"公司"）首次公开发行人民 币普通股（A 股）股票 2,667.00 万股，每股面值 1.00 元，发行价格为 22.70 元 /股，募集资金总额为人民币 605,409,000.00 元，扣除相关发行费用后实际募集 资金净额为人民币 540,808,306.61 元。天职国际会计事务所（特殊普通合伙） 对本次募集资金到位情况进行了审验，并出具《验资报告》（天职业字[2021]43057 号）。 二、募集资金监管协议的签订情况和募集资金专户开立情况 公司于 2024 年 12 月 26 日召开第五届董事会第十次会议、第五届监事会第 八次会议，于 2025 年 1 月 14 日召开公司 2025 年第一次临时股东大会，审议通 过了《关于变更部分募集资金用途及新增募集资金投资项目的议案》，同意公司 终 ...

Core Viewpoint - The company, Hunan Hengguang Technology Co., Ltd., announced that its board member and vice president, Zhu Youliang, and financial director, Tan Yanchun, plan to reduce their shareholdings in the company through centralized bidding transactions within three months after a 15-day notice period [1][2]. Group 1: Shareholding Reduction Plans - Zhu Youliang holds 463,750 shares (0.4201% of total shares) and plans to reduce his holdings by up to 115,930 shares (0.1050% of total shares) [1]. - Tan Yanchun holds 424,500 shares (0.3845% of total shares) and plans to reduce her holdings by up to 106,125 shares (0.0961% of total shares) [1]. Group 2: Commitments by Shareholders - Both Zhu Youliang and Tan Yanchun committed not to transfer or manage their indirectly held shares for twelve months from the date of the company's stock listing [2]. - They also agreed to extend the lock-up period by six months if the stock price falls below the issue price for 20 consecutive trading days within the first six months post-listing [2]. Group 3: Compliance and Reporting - The shareholders have committed to timely reporting any changes in their shareholdings and will comply with relevant laws and regulations regarding share transfers [3][5]. - The company confirmed that the planned share reduction aligns with previously disclosed intentions and commitments [5].

证券代码：301118 证券简称：恒光股份 公告编号：2025-014 二、本次减持计划的主要内容 注：如遇公司股票在减持期间发生除权、除息事项的，减持股份数量作相应调整。 湖南恒光科技股份有限公司 关于董事、高级管理人员减持股份预披露公告 公司董事、副总裁兼董事会秘书朱友良、财务总监谭艳春保证向本公司提供 的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 1、直接持有公司股份463,750股（占公司总股本比例0.4201%）的董事、副 总裁兼董事会秘书朱友良先生计划在本公告披露之日起15个交易日后的3个月内 以集中竞价交易方式减持公司股份不超过115,930股（占公司总股本比例 0.1050%）。 2、直接持有公司股份424,500股（占公司总股本比例0.3845%）的财务总监 谭艳春女士计划在本公告披露之日起15个交易日后的3个月内以集中竞价交易方 式减持公司股份不超过106,125股（占公司总股本比例0.0961%）。 湖南恒光科技股份有限公司（以下简称"公司"或"恒光股份"）于近日收 到公司董事、副总裁兼董 ...

Core Insights - Hengguang Co., Ltd. experienced a trading halt with a daily price increase of 20.00% and a turnover rate of 11.23% [2] - The total trading volume for the day reached 266 million yuan, with a price fluctuation of 10.18% [2] - Institutional investors showed a net selling of 454,100 yuan, while brokerage seats collectively recorded a net buying of 29.95 million yuan [2] Trading Data - The top five brokerage seats accounted for a total transaction volume of 67.93 million yuan, with buying transactions amounting to 48.71 million yuan and selling transactions at 19.21 million yuan, resulting in a net buying of 29.50 million yuan [2] - Among the brokerage seats, three institutional specialized seats were involved, with a total buying amount of 9.56 million yuan and selling amount of 10.01 million yuan, leading to a net selling of 454,100 yuan [2] Fund Flow - The stock saw a net inflow of 61.23 million yuan from major funds, with a significant single order net inflow of 85.19 million yuan, while large orders experienced a net outflow of 23.96 million yuan [2] - Over the past five days, the net inflow of major funds totaled 53.04 million yuan [2]

一、担保情况概述 湖南恒光科技股份有限公司（以下简称"公司"或"恒光股份"）于 2025 年 1 月 24 日召开第五届董事会第十一次会议、于 2025 年 2 月 13 日召开 2025 年第 二次临时股东大会，审议通过了《关于公司及子公司向金融机构申请综合授信额 度及担保额度的议案》，同意公司及子公司向银行等金融机构申请总额不超过人 民币 18 亿元的授信额度，授信使用额度不超过人民币 15 亿元，并由公司为全资 及控股子公司向银行等金融机构申请的授信提供不超过人民币 6 亿元的担保，综 合授信额度的申请期限和担保额度的授权期限均为自公司 2025 年第二次临时股 东大会审议通过之日起的十二个月内有效，在有效期限内，综合授信及担保额度 可循环使用。 具体内容详见公司在巨潮资讯网披露的《关于公司及子公司向金融机构申请 综合授信额度及担保额度的公告》（公告编号：2025-004）。 证券代码：301118 证券简称：恒光股份 公告编号：2025-013 湖南恒光科技股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 ...